New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 2, 2014
10:47 EDTMYGNMyriad Genetics to participate in hereditary cancer research collaboration
Myriad Genetics said it will team up with cancer experts from the Memorial Sloan Kettering Cancer Center (MSKCC), Mayo Clinic, Abramson Cancer Center of the University of Pennsylvania and other laboratories in a new partnership to advance the understanding of the risks associated with multiple cancer genes. Specifically, the partners will collaborate on the creation of a research study called the Prospective Registry of Multiplex Testing, or PROMPT, to which Myriad will contribute thousands of genetic mutations and its scientific expertise gained from having tested over 1.3M patients for hereditary cancer risk.
News For MYGN From The Last 14 Days
Check below for free stories on MYGN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 9, 2014
07:11 EDTMYGNMyriad Genetics presented results from myPath Melanoma test clinical study
Subscribe for More Information
September 3, 2014
16:14 EDTMYGNMyriad Genetics says myRisk test improves detection of cancer-causing mutations
Myriad Genetics announced that the Myriad myRisk Hereditary Cancer test significantly improved the detection of cancer-causing mutations by 46% in patients with breast cancer in a new study published in the journal Cancer.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use